一名15岁女孩泌乳素瘤的医学管理 - Suppr

Suppr

超能文献

Medical Management of a Prolactinoma in a 15-Year-Old Girl.

作者信息

Bowling Morgan S, Zamudio Alejandro, Jaffery Fatema

机构信息

Department of Pediatrics Newark Beth Israel Medical Center Newark, New Jersey.

出版信息

J Pediatr. 2018 Sep;200:287-287.e1. doi: 10.1016/j.jpeds.2018.03.054. Epub 2018 Apr 22.

DOI:10.1016/j.jpeds.2018.03.054

PMID:29685620

Abstract

摘要

相似文献

Medical Management of a Prolactinoma in a 15-Year-Old Girl.

J Pediatr. 2018 Sep;200:287-287.e1. doi: 10.1016/j.jpeds.2018.03.054. Epub 2018 Apr 22.

Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis.

Pituitary. 2015 Oct;18(5):745-51. doi: 10.1007/s11102-014-0617-2.

Visual vignette. Prolactinoma.

Endocr Pract. 2008 Mar;14(2):256. doi: 10.4158/EP.14.2.256.

Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis.

J Clin Endocrinol Metab. 2004 Apr;89(4):1704-11. doi: 10.1210/jc.2003-030979.

Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report.

J Med Case Rep. 2019 Jun 16;13(1):183. doi: 10.1186/s13256-019-2071-2.

Start low, go slowly - mental abnormalities in young prolactinoma patients under cabergoline therapy.

J Pediatr Endocrinol Metab. 2019 Sep 25;32(9):969-977. doi: 10.1515/jpem-2018-0475.

Mean platelet volume in patients with prolactinoma.

Arch Endocrinol Metab. 2016 Aug;60(4):319-22. doi: 10.1590/2359-3997000000054. Epub 2016 Feb 16.

Beneficial Effects of High Doses of Cabergoline in the Treatment of Giant Prolactinoma Resistant to Dopamine Agonists: A Case Report with a 21-Year Follow-Up.

Horm Res Paediatr. 2018;89(1):63-70. doi: 10.1159/000479511. Epub 2017 Sep 26.

[Efficacy of cabergoline in the treatment of macroprolactinoma].

Presse Med. 2003 Jan 18;32(2):71-2.

[Selection of management tactics in treatment of giant prolactin-secreting pituitary adenomas].

Zh Vopr Neirokhir Im N N Burdenko. 2009 Apr-Jun(2):23-8; discussion 28-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Medical Management of a Prolactinoma in a 15-Year-Old Girl.

作者信息

Bowling Morgan S, Zamudio Alejandro, Jaffery Fatema

机构信息

Department of Pediatrics Newark Beth Israel Medical Center Newark, New Jersey.

出版信息

J Pediatr. 2018 Sep;200:287-287.e1. doi: 10.1016/j.jpeds.2018.03.054. Epub 2018 Apr 22.

DOI:10.1016/j.jpeds.2018.03.054

PMID:29685620

Abstract

摘要

相似文献

Medical Management of a Prolactinoma in a 15-Year-Old Girl.

J Pediatr. 2018 Sep;200:287-287.e1. doi: 10.1016/j.jpeds.2018.03.054. Epub 2018 Apr 22.

Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis.

Pituitary. 2015 Oct;18(5):745-51. doi: 10.1007/s11102-014-0617-2.

Visual vignette. Prolactinoma.

Endocr Pract. 2008 Mar;14(2):256. doi: 10.4158/EP.14.2.256.

Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis.

J Clin Endocrinol Metab. 2004 Apr;89(4):1704-11. doi: 10.1210/jc.2003-030979.

Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report.

J Med Case Rep. 2019 Jun 16;13(1):183. doi: 10.1186/s13256-019-2071-2.

Start low, go slowly - mental abnormalities in young prolactinoma patients under cabergoline therapy.

J Pediatr Endocrinol Metab. 2019 Sep 25;32(9):969-977. doi: 10.1515/jpem-2018-0475.

Mean platelet volume in patients with prolactinoma.

Arch Endocrinol Metab. 2016 Aug;60(4):319-22. doi: 10.1590/2359-3997000000054. Epub 2016 Feb 16.

Beneficial Effects of High Doses of Cabergoline in the Treatment of Giant Prolactinoma Resistant to Dopamine Agonists: A Case Report with a 21-Year Follow-Up.

Horm Res Paediatr. 2018;89(1):63-70. doi: 10.1159/000479511. Epub 2017 Sep 26.

[Efficacy of cabergoline in the treatment of macroprolactinoma].

Presse Med. 2003 Jan 18;32(2):71-2.

[Selection of management tactics in treatment of giant prolactin-secreting pituitary adenomas].

Zh Vopr Neirokhir Im N N Burdenko. 2009 Apr-Jun(2):23-8; discussion 28-9.